RetinaLyze Nordic ApS: Financial statements 2023
CVR: 37219444
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
RetinaLyze Nordic ApS (CVR 37219444) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 331,668 and a net result of DKK 256,016 compared with DKK 191,925 the year before. That is an increase of 31.2% compared with the year before. Equity in the 2023 report amounted to DKK 666,273. The solvency ratio was 90.2%.
- Gross Profit
- DKK 331,668
- Profit/Loss
- DKK 256,016
- Equity
- DKK 666,273
- Total Assets
- DKK 738,482
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 332K | 256K | 666K | - |
| 2022 | - | 253K | 192K | 410K | - |
| 2021 | - | 140K | 105K | 218K | - |
| 2020 | - | 53K | 33K | 114K | - |
| 2019 | - | 107K | 79K | 80K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
RetinaLyze Nordic ApS has published its annual report for 2022. Gross profit came to DKK 252,809, and the net result was DKK 191,925.
About RetinaLyze Nordic ApS
RetinaLyze Nordic ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company is registered under the industry Ikke-specialiseret engroshandel. The company was previously named UniVision ApS. The management consists of Peter Jørgensen. The company is owned by MountVision ApS. In 2025, the company reported a gross profit of DKK 213,373 and a net result of DKK 158,437 compared with DKK 145,520 the year before. Equity in the 2025 report amounted to DKK 218,437.